Hepatorenal syndrome classification: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
mNo edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Classification== | ==Classification== | ||
The hepatorenal syndrome is defined as renal failure that occurs in the setting of liver disease as follows | The hepatorenal syndrome is defined as renal failure that occurs in the setting of liver disease as follows: | ||
===Type I HRS=== | ===Type I HRS=== | ||
Line 19: | Line 19: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] |
Revision as of 15:15, 18 July 2016
Hepatorenal syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatorenal syndrome classification On the Web |
American Roentgen Ray Society Images of Hepatorenal syndrome classification |
Risk calculators and risk factors for Hepatorenal syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
The hepatorenal syndrome is defined as renal failure that occurs in the setting of liver disease as follows:
Type I HRS
Type I HRS is characterized by rapidly progressive renal failure with a doubling of serum creatinine to a level greater than 221 μmol/L (2.5 mg/dL) or a halving of the creatinine clearance to less than 20 mL/min over a period of less than 2 weeks.
Type II HRS
Type II HRS is characterized by a slowly progressive:
- Increase in serum creatinine level to greater than 133 μmol/L (1.5 mg/dL) or a creatinine clearance of less than 40 mL/min
- Urine sodium < 10 meq/dl[1]